IL10 and COVID-19: Altogether, our study highlights the absence of a strong anti‐viral response against SARS‐CoV‐2 across mild‐to‐severe COVID‐19 patients and the elevated presence of anti‐inflammatory IL‐10‐producing regulatory T cells in the severely affected patients.